These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 23554130)
21. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol. Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256 [TBL] [Abstract][Full Text] [Related]
22. Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents. Witschi H; Espiritu I; Suffia M; Pinkerton KE Carcinogenesis; 2002 Feb; 23(2):289-94. PubMed ID: 11872634 [TBL] [Abstract][Full Text] [Related]
23. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort. Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648 [TBL] [Abstract][Full Text] [Related]
24. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Vigushin DM; Poon GK; Boddy A; English J; Halbert GW; Pagonis C; Jarman M; Coombes RC Cancer Chemother Pharmacol; 1998; 42(2):111-7. PubMed ID: 9654110 [TBL] [Abstract][Full Text] [Related]
25. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients. Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988 [TBL] [Abstract][Full Text] [Related]
26. The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer. Kamal A; Boerner J; Assad H; Chen W; Simon MS Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273534 [TBL] [Abstract][Full Text] [Related]
27. Human metabolism of the experimental cancer therapeutic agent d-limonene. Crowell PL; Elson CE; Bailey HH; Elegbede A; Haag JD; Gould MN Cancer Chemother Pharmacol; 1994; 35(1):31-7. PubMed ID: 7987974 [TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells. Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406 [TBL] [Abstract][Full Text] [Related]
29. Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes. Maltzman TH; Christou M; Gould MN; Jefcoate CR Carcinogenesis; 1991 Nov; 12(11):2081-7. PubMed ID: 1934293 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action. Karlson J; Borg-Karlson AK; Unelius R; Shoshan MC; Wilking N; Ringborg U; Linder S Anticancer Drugs; 1996 Jun; 7(4):422-9. PubMed ID: 8826611 [TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression. Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235 [TBL] [Abstract][Full Text] [Related]
32. Changes of peel essential oil composition of four Tunisian citrus during fruit maturation. Bourgou S; Rahali FZ; Ourghemmi I; Saïdani Tounsi M ScientificWorldJournal; 2012; 2012():528593. PubMed ID: 22645427 [TBL] [Abstract][Full Text] [Related]
33. Re: Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. Yu H J Natl Cancer Inst; 1999 Oct; 91(19):1685. PubMed ID: 10511597 [No Abstract] [Full Text] [Related]
34. Inhibition of protein prenylation by metabolites of limonene. Hardcastle IR; Rowlands MG; Barber AM; Grimshaw RM; Mohan MK; Nutley BP; Jarman M Biochem Pharmacol; 1999 Apr; 57(7):801-9. PubMed ID: 10075086 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of rat mammary carcinogenesis by monoterpenoids. Russin WA; Hoesly JD; Elson CE; Tanner MA; Gould MN Carcinogenesis; 1989 Nov; 10(11):2161-4. PubMed ID: 2509095 [TBL] [Abstract][Full Text] [Related]
36. Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in RAW 264.7 macrophages. Yoon WJ; Lee NH; Hyun CG J Oleo Sci; 2010; 59(8):415-21. PubMed ID: 20625233 [TBL] [Abstract][Full Text] [Related]
37. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt. Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605 [TBL] [Abstract][Full Text] [Related]
39. In vitro comparative analysis of antiproliferative activity of essential oil from mandarin peel and its principal component limonene. Manassero CA; Girotti JR; Mijailovsky S; García de Bravo M; Polo M Nat Prod Res; 2013; 27(16):1475-8. PubMed ID: 22943501 [TBL] [Abstract][Full Text] [Related]
40. Chemical composition and insecticidal activity of the essential oil of Illicium pachyphyllum fruits against two grain storage insects. Liu P; Liu XC; Dong HW; Liu ZL; Du SS; Deng ZW Molecules; 2012 Dec; 17(12):14870-81. PubMed ID: 23519259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]